Alloy Therapeutics
Waltham · Founded 2017
About Alloy Therapeutics
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $128.2M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2022)
- Website: alloytx.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alloy-therapeutics-50624 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.